UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma

Journal of clinical oncology, 2000-01, Vol.18 (1), p.12-17

2000

Link zum Volltext

Verfügbarkeit prüfen

Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1244-1251

1997

Link zum Volltext

Verfügbarkeit prüfen

Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma

Journal of clinical oncology, 2000-01, Vol.18 (1), p.236-237

2000

Link zum Volltext

Verfügbarkeit prüfen

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5436-5442

2008

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2874-2880

2016

Link zum Volltext

Verfügbarkeit prüfen

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2016-12, Vol.34 (34), p.4142-4150

2016

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1800-1816

1995

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma: The final analysis of cohort 1

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9586-9586

2022

Link zum Volltext

Verfügbarkeit prüfen

System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3652-3661

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22059-e22059

2020

Link zum Volltext

Verfügbarkeit prüfen

Expanding veteran treatment access points through Close To Me (CTM) infusion service

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1519-1519

2023

Link zum Volltext

Verfügbarkeit prüfen

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9592-9592

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1498-1504

2003

Link zum Volltext

Verfügbarkeit prüfen

Conjunctival melanoma: bladder and upper urinary tract metastases

Journal of clinical oncology, 2011-03, Vol.29 (9), p.e216-e219

2011

Link zum Volltext

Verfügbarkeit prüfen

Characteristics associated with functional resilience versus functional decline among adult patients with advanced non–small cell lung cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1538-1538

2022

Link zum Volltext

Verfügbarkeit prüfen

Unique clustering of uveal melanoma in young females

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20054-e20054

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2626-2626

2023

Link zum Volltext

Verfügbarkeit prüfen

The differential response to immune checkpoint inhibitors (ICIs) according to mismatch repair alterations in gastrointestinal (GI) non-colorectal cancers (non-CRCs) and the impact of dual vs. monotherapy ICIs on survival in GI (CRC and non-CRC) cancers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2620-2620

2023

Link zum Volltext

Verfügbarkeit prüfen

Not all treated KRAS- mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4020-4020

2023

Link zum Volltext

Verfügbarkeit prüfen

KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4150-4150

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic indicators of KRAS G12X mutations in pancreatic cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.735-735

2023

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic and transcriptomic characterization of small bowel adenocarcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4018-4018

2022

Link zum Volltext

Verfügbarkeit prüfen

First clinical and immunogenicity results including all subjects enrolled in a phase I study of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2515-2515

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

PublikationsformNewsletter-Artikel

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(126)

Sprache

Englisch
(126)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(13)
Oncology
(13)
Science & Technology
(13)
Male
(12)
Female
(11)
Middle Aged
(11)
Aged
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Adult
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Cancer Research
(4)
Original Reports
(4)
Treatment Outcome
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Drug Administration Schedule
(3)
Pharmacology. Drug Treatments
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma

Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients

Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma: The final analysis of cohort 1

System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation

A randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma

Expanding veteran treatment access points through Close To Me (CTM) infusion service

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

Conjunctival melanoma: bladder and upper urinary tract metastases

Characteristics associated with functional resilience versus functional decline among adult patients with advanced non–small cell lung cancer

Unique clustering of uveal melanoma in young females

Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC

The differential response to immune checkpoint inhibitors (ICIs) according to mismatch repair alterations in gastrointestinal (GI) non-colorectal cancers (non-CRCs) and the impact of dual vs. monotherapy ICIs on survival in GI (CRC and non-CRC) cancers

Not all treated KRAS- mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome

KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen

Prognostic indicators of KRAS G12X mutations in pancreatic cancer

Comprehensive genomic and transcriptomic characterization of small bowel adenocarcinoma

First clinical and immunogenicity results including all subjects enrolled in a phase I study of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI)

Aktive Filter

Suchergebnisse filtern